SARS-CoV-2 Aiming for the Heart: A Multicenter Italian Perspective About Cardiovascular Issues in COVID-19

Matteo Briguglio1, Mauro Porta2, Francesca Zuffada3

  • 1IRCCS Orthopedic Institute Galeazzi, Scientific Direction, Milan, Italy.

Frontiers in Physiology
|November 26, 2020
PubMed

Insights

Coronavirus disease 2019 (COVID-19) causes severe cardiovascular complications, including myocardial injury and thrombosis. Understanding these cardiac effects is crucial for developing effective treatments for COVID-19 patients.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Pathophysiology

Background:

  • The global impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 2019 (COVID-19) continues to strain healthcare systems worldwide.
  • COVID-19 presents with unpredictable symptoms, often exacerbated by advanced age, malnutrition, and cardiovascular comorbidities.
  • The virus primarily affects the lungs but can lead to fatal cardiovascular consequences in susceptible individuals.

Purpose of the Study:

  • To elucidate the pathophysiology of COVID-19 from a cardiological perspective.
  • To highlight the major cellular and clinical manifestations of COVID-19 affecting the cardiovascular system.
  • To emphasize the importance of a cardiology-focused approach to understanding and managing COVID-19.

Main Methods:

  • Review of current literature on SARS-CoV-2 infection and its cardiovascular implications.
  • Analysis of cellular mechanisms and clinical presentations of cardiac involvement in COVID-19.
  • Emphasis on the cardiological perspective of viral transmission and its effects.

Main Results:

  • SARS-CoV-2 can induce myocardial injuries, vasculitis-like syndromes, and atherothrombotic events.
  • Electrocardiogram abnormalities may indicate pericardial effusion or cardiac inflammation.
  • Microthrombi can lead to ischemic damage, stroke, and autonomic dysfunction.

Conclusions:

  • COVID-19 presents significant cardiovascular challenges, including arrhythmias, coronary syndromes, and thrombotic events.
  • Tailored cardiological interventions are essential for managing reduced ejection fraction, autonomic dysfunction, and thrombosis.
  • Further research and global assessment of therapeutic strategies are needed for effective evidence-based treatments.

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
221
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
217
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
188
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
200
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
691
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
261